165 related articles for article (PubMed ID: 17315037)
1. Technology insight: gene therapy and its potential role in the treatment of medullary thyroid carcinoma.
Messina M; Robinson BG
Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):290-301. PubMed ID: 17315037
[TBL] [Abstract][Full Text] [Related]
2. Effective gene therapy for medullary thyroid carcinoma using recombinant adenovirus inducing tumor-specific expression of interleukin-12.
Yamazaki M; Zhang R; Straus FH; Messina M; Robinson BG; Hashizume K; DeGroot LJ
Gene Ther; 2002 Jan; 9(1):64-74. PubMed ID: 11850724
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of systemic targeting of RET oncogene-based MTC with tumor-selective peptide-tagged Ad vectors in clinical mouse models.
Schmidt A; Eipel C; Fürst K; Sommer N; Pahnke J; Pützer BM
Gene Ther; 2011 Apr; 18(4):418-23. PubMed ID: 21228881
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets.
Cerrato A; De Falco V; Santoro M
J Mol Endocrinol; 2009 Oct; 43(4):143-55. PubMed ID: 19383830
[TBL] [Abstract][Full Text] [Related]
5. Medullary thyroid carcinoma: autologous tumor cell lines for dendritic cell vaccination.
Pfragner R; Skofitsch G; Höger H; Jech M; Rinner B; Siegl V; Niederle B; Gnant M; Friedl J; Stift A
Anticancer Res; 2005; 25(6B):4225-30. PubMed ID: 16309220
[TBL] [Abstract][Full Text] [Related]
6. New therapeutic approaches to treat medullary thyroid carcinoma.
Schlumberger M; Carlomagno F; Baudin E; Bidart JM; Santoro M
Nat Clin Pract Endocrinol Metab; 2008 Jan; 4(1):22-32. PubMed ID: 18084343
[TBL] [Abstract][Full Text] [Related]
7. Beyond RET: potential therapeutic approaches for advanced and metastatic medullary thyroid carcinoma.
Santarpia L; Ye L; Gagel RF
J Intern Med; 2009 Jul; 266(1):99-113. PubMed ID: 19522829
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin-specific transcription and splicing targets gene-directed enzyme prodrug therapy to medullary thyroid carcinoma cells.
Messina M; Yu DM; Both GW; Molloy PL; Robinson BG
J Clin Endocrinol Metab; 2003 Mar; 88(3):1310-8. PubMed ID: 12629124
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy of brain and endocrine tumors.
Palù G; Bonaguro R; Gnatta E; Franchin E; Barzon L
Croat Med J; 2001 Aug; 42(4):473-7. PubMed ID: 11471203
[TBL] [Abstract][Full Text] [Related]
10. Medullary thyroid cancer: therapeutic targets and molecular markers.
Ball DW
Curr Opin Oncol; 2007 Jan; 19(1):18-23. PubMed ID: 17133107
[TBL] [Abstract][Full Text] [Related]
11. New therapeutic advances in the management of progressive thyroid cancer.
Woyach JA; Shah MH
Endocr Relat Cancer; 2009 Sep; 16(3):715-31. PubMed ID: 19218279
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and therapeutic aspects in medullary thyroid carcinoma.
Safioleas M; Stamatakos M; Karampali E; Rompoti N; Mouzopoulos G; Lygidakis N
Chirurgia (Bucur); 2006; 101(2):121-6. PubMed ID: 16752676
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell vaccination induces tumor epitope-specific Th1 immune response in medullary thyroid carcinoma.
Papewalis C; Wuttke M; Jacobs B; Domberg J; Willenberg H; Baehring T; Cupisti K; Raffel A; Chao L; Fenk R; Seissler J; Scherbaum WA; Schott M
Horm Metab Res; 2008 Feb; 40(2):108-16. PubMed ID: 18283628
[TBL] [Abstract][Full Text] [Related]
14. Expression of v-Ha-ras driven by the calcitonin/calcitonin gene-related peptide promoter: a novel transgenic murine model for medullary thyroid carcinoma.
Johnston D; Hatzis D; Sunday ME
Oncogene; 1998 Jan; 16(2):167-77. PubMed ID: 9464534
[TBL] [Abstract][Full Text] [Related]
15. Gene therapeutic approaches for medullary thyroid carcinoma treatment.
Drosten M; Pützer BM
J Mol Med (Berl); 2003 Jul; 81(7):411-9. PubMed ID: 12811413
[TBL] [Abstract][Full Text] [Related]
16. Treatments sought for intractable forms of thyroid cancer.
Ziegler J
J Natl Cancer Inst; 1997 Dec; 89(23):1752-4. PubMed ID: 9392613
[No Abstract] [Full Text] [Related]
17. Gene therapy in thyroid cancer.
Spitzweg C
Horm Metab Res; 2009 Jun; 41(6):500-9. PubMed ID: 19434562
[TBL] [Abstract][Full Text] [Related]
18. The cholecystokinin2-receptor mediates calcitonin secretion, gene expression, and proliferation in the human medullary thyroid carcinoma cell line, TT.
Bläker M; Arrenberg P; Stange I; Schulz M; Burghardt S; Michaelis H; Pace A; Greten H; von Schrenck T; de Weerth A
Regul Pept; 2004 Apr; 118(1-2):111-7. PubMed ID: 14759564
[TBL] [Abstract][Full Text] [Related]
19. Medullary thyroid carcinoma and biomarkers: past, present and future.
van Veelen W; de Groot JW; Acton DS; Hofstra RM; Höppener JW; Links TP; Lips CJ
J Intern Med; 2009 Jul; 266(1):126-40. PubMed ID: 19522831
[TBL] [Abstract][Full Text] [Related]
20. Management of medullary thyroid carcinoma.
Jiménez C; Hu MI; Gagel RF
Endocrinol Metab Clin North Am; 2008 Jun; 37(2):481-96, x-xi. PubMed ID: 18502338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]